This brand name is authorized in Austria, Canada, Cyprus, Germany, Estonia, Spain, Finland, France, Hong Kong, Croatia, Ireland, Malta, Mexico, Netherlands, New Zealand, Poland, Romania, Singapore, Turkey, United Kingdom, South Africa
The drug NIMOTOP contains one active pharmaceutical ingredient (API):
|
1
Nimodipine
UNII 57WA9QZ5WH - NIMODIPINE
|
|
Nimodipine is a dihydropyridine calcium channel blocker with particular cerebrovascular effect. Nimodipine increases cerebral perfusion, particularly in poorly perfused areas, by arterial dilatation, an effect which is proportionately greater in smaller than in larger vessels. |
Below package inserts are available for further reading:
| Title | Information Source | Document Type | |
|---|---|---|---|
| NIMOTOP Film-coated tablet | Medicines & Healthcare Products Regulatory Agency (GB) | MPI, EU: SmPC | |
| NIMOTOP 0.02% Solution for infusion | Medicines & Healthcare Products Regulatory Agency (GB) | MPI, EU: SmPC |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC code | Group title | Classification |
|---|---|---|
| C08CA06 | Nimodipine | C Cardiovascular system → C08 Calcium channel blockers → C08C Selective calcium channel blockers with mainly vascular effects → C08CA Dihydropyridine derivatives |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| Country: CA | Health Products and Food Branch | Identifier(s): 02325926 |
| Country: DE | Bundesinstitut für Arzneimittel und Medizinprodukte | Identifier(s): 00165333, 01549969, 03673254, 06151384 |
| Country: EE | Ravimiamet | Identifier(s): 1006254, 1006287, 1510221 |
| Country: ES | Centro de información online de medicamentos de la AEMPS | Identifier(s): 58075 |
| Country: FI | Lääkealan turvallisuus- ja kehittämiskeskus | Identifier(s): 086553, 086587 |
| Country: FR | Base de données publique des médicaments | Identifier(s): 61339638, 65726536 |
| Country: GB | Medicines & Healthcare Products Regulatory Agency | Identifier(s): 373063, 38794 |
| Country: HK | Department of Health Drug Office | Identifier(s): 28973, 28974 |
| Country: IE | Health Products Regulatory Authority | Identifier(s): 36517 |
| Country: MT | Medicines Authority | Identifier(s): AA639/02402, MA639/02401 |
| Country: MX | Comisión Federal para la Protección contra Riesgos Sanitarios | Identifier(s): 122M88, 123M88 |
| Country: NL | Z-Index G-Standaard | Identifier(s): 13484494 |
| Country: NL | Z-Index G-Standaard, PRK | Identifier(s): 27588, 27596 |
| Country: NZ | Medicines and Medical Devices Safety Authority | Identifier(s): 6608, 6609 |
| Country: PL | Rejestru Produktów Leczniczych | Identifier(s): 100034556, 100047470, 100247447, 100264180, 100293252, 100293648, 100323869, 100332259, 100363490, 100396006, 100421247, 100423677, 100425311, 100465827 |
| Country: RO | Agenția Națională a Medicamentului și a Dispozitivelor Medicale | Identifier(s): W63887001, W63887002, W63888001, W63888002, W63888003, W63888004 |
| Country: SG | Health Sciences Authority | Identifier(s): 06931P, 09111P |
| Country: TR | İlaç ve Tıbbi Cihaz Kurumu | Identifier(s): 8699546010387, 8699546750399 |
| Country: ZA | Health Products Regulatory Authority | Identifier(s): T/7.1/229, T/7.1/230 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
